Skip to main content

Lotrimin News

12.8 Percent of Unique Prescribers Prescribed Topical Antifungals in 2021

THURSDAY, Jan. 11, 2024 – In 2021, 12.8 percent of unique prescribers in Medicare Part D prescribed topical antifungals, with about 6.5 million topical antifungal prescriptions filled, at a total...

Overuse of Antifungal Skin Meds Could Be Driving Drug-Resistant Disease

THURSDAY, Jan. 11, 2024 – U.S. doctors are prescribing antifungal creams to patients with skin complaints at rates so high they could be contributing to the rise of drug-resistant infections, new...

FDA Medwatch Alert: Voluntary Recall of Certain Family Dollar Over-the-Counter Products

July 21, 2022 – Family Dollar is initiating a voluntary retail level product recall of certain products regulated by the U.S. Food and Drug Administration (FDA) that were stored and inadvertently...

FDA Medwatch Alert: Bayer Issues Voluntary Recall of Specific Lotrimin® and Tinactin® Spray Products Due to the Presence of Benzene

WHIPPANY, N.J., October 1, 2021 – Bayer is voluntarily recalling all unexpired Lotrimin® AF and Tinactin® spray products with lot numbers beginning with TN, CV or NAA, distributed between September 2...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Vaginal Yeast Infection, Tinea Corporis

Lotrimin patient information at Drugs.com